Everest Organics Q1 Results: Net profit falls 20% YoY to ₹111.34 lakh

1 min read     Updated on 17 Aug 2026, 12:14 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Everest Organics posted a net profit of ₹111.34 lakh in Q1FY27, down 20.8% YoY, as revenue slipped 10% to ₹4,843.06 lakh. Pre-tax profits declined more sharply at 29.4%, signaling margin compression. Reserves grew to ₹6,688.11 lakh, while equity capital remained stable at ₹971.05 lakh.

powered bylight_fuzz_icon
48494630

*this image is generated using AI for illustrative purposes only.

Everest Organics reported a net profit of ₹111.34 lakh for the quarter ended June 30, 2026, marking a decline from the ₹140.52 lakh recorded in the corresponding period of FY25. Revenue from operations for Q1FY27 stood at ₹4,843.06 lakh, compared to ₹5,381.32 lakh in Q1FY25.

The company’s net profit before tax (PBT) decreased to ₹152.84 lakh in the current quarter, down from ₹216.43 lakh a year ago. Earnings per share (EPS), both basic and diluted, fell to ₹1.15 per share, lower than the ₹1.45 reported in Q1FY25.

Financial Performance

The Board of Directors approved the unaudited standalone financial results at a meeting held on August 14, 2026. The results have been reviewed by the Audit Committee and are subject to a limited review report by the auditors.

Metric: Q1FY27 Q1FY26 Change
Revenue from Operations: ₹4,843.06 lakh ₹5,381.32 lakh -10.0%
Net Profit Before Tax: ₹152.84 lakh ₹216.43 lakh -29.4%
Net Profit After Tax: ₹111.34 lakh ₹140.52 lakh -20.8%
EPS (Basic/Diluted): ₹1.15 ₹1.45 -20.7%

Balance Sheet Position

As of June 30, 2026, Everest Organics’ reserves increased to ₹6,688.11 lakh, up from ₹6,164.15 lakh in the same period last year. Equity share capital remained unchanged at ₹971.05 lakh. Total comprehensive income attributable to owners was ₹111.34 lakh, consistent with the net profit for the period.

What the Numbers Show

The divergence between revenue and profit declines highlights margin pressure during the quarter. While revenue contracted by approximately 10%, pre-tax profits fell nearly 30%, indicating that cost structures did not adjust proportionately to the lower top-line growth. This compression in operating efficiency is reflected in the wider gap between the PBT and PAT figures compared to the prior year.

Historical Stock Returns for Everest Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+0.19%-3.29%-12.27%-12.88%-17.02%-4.28%

What specific cost drivers contributed to the disproportionate 29.4% drop in PBT compared to the 10% revenue decline, and are these costs structural or temporary?

How does Everest Organics plan to address the margin compression observed in Q1FY27 to restore profitability growth in subsequent quarters?

Are there any strategic initiatives or product mix changes planned to reverse the revenue contraction trend seen in the quarter ended June 30, 2026?

Everest Organics accepts resignation of Company Secretary Shweta Singh

1 min read     Updated on 22 Jun 2026, 11:34 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Everest Organics Limited has accepted the resignation of Ms. Shweta Singh as Company Secretary and Compliance Officer, effective June 22, 2026. Singh cited personal reasons and career growth for her departure. The Managing Director will serve as the interim Compliance Officer until a successor is appointed.

powered bylight_fuzz_icon
43653835

*this image is generated using AI for illustrative purposes only.

Everest Organics Limited has accepted the resignation of Ms. Shweta Singh as Company Secretary and Compliance Officer, effective June 22, 2026. The resignation, citing personal reasons and career growth, was received by the company on June 21, 2026. The Managing Director will assume the role of Compliance Officer on an interim basis until a new appointment is made.

The company disclosed the change in a filing to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation letter will be placed before the upcoming Board meeting for formal acceptance and noting, in accordance with the Companies Act, 2013 and SEBI LODR Regulations.

Resignation Details

The following table outlines the key particulars regarding the change in the compliance officer position:

Particulars Details
Reason for change Resignation
Name of outgoing Company Secretary Ms. Shweta Singh, ACS No. 66353
Date of cessation June 22, 2026
Reason for resignation Personal reasons and Career growth.
Disclosure of relationships between directors Not Applicable

Everest Organics stated that it will make necessary arrangements to appoint a new Company Secretary and Compliance Officer in accordance with applicable laws and will inform the stock exchanges subsequently. Until then, the Managing Director has been designated as the Compliance Officer.

Historical Stock Returns for Everest Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+0.19%-3.29%-12.27%-12.88%-17.02%-4.28%

What is the expected timeline for appointing a permanent Company Secretary and Compliance Officer?

How will the Managing Director's dual role impact the company's operational efficiency during the interim period?

Will the resignation of the compliance officer lead to any delays in regulatory filings or disclosures?

More News on Everest Organics

1 Year Returns:-17.02%